4/A

FORM 4/A SUBMISSION

Company: Amylyx Pharmaceuticals, Inc.
Filed: March 24, 2023
Period of Report: March 16, 2023
Accession Number: 0000899243-23-009602

View Document ↗ View on SEC.gov ↗